News

March 29, 2017March 29, 2017

Blood Levels of MicroRNA May Be Biomarker for Early Diagnosis of Malignant Mesothelioma

News

A small RNA molecule called miR-132-3p was found to be downregulated in blood samples of mesothelioma patients. In combination with other biomarkers, this microRNA could improve the early detection and ... Read more

March 28, 2017March 28, 2017

ADOA to Present Brazilian Group its 2017 ‘Tribute of Unity’ Award at Upcoming Asbestos Conference

News

The Asbestos Disease Awareness Organization will hold its 13th Annual International Asbestos Awareness and Prevention Conference next month to help raise awareness of asbestos-related mesothelioma. The meeting, set for April 7-9 at the Renaissance Arlington Capital ... Read more

March 27, 2017March 27, 2017

Researchers Developing Better Diagnostic Test for Malignant Mesothelioma

News

Scientists are developing a more effective diagnostic tool for mesothelioma by combining the blood levels of mesothelin (a marker for mesothelioma) and detecting fractions of a protein called MPF, according to a new study. ... Read more

March 24, 2017March 24, 2017

YS110’s First-in-human Phase 1 Trial Shows Promising Results in CD26-positive Mesotheliomas, Other Tumors

News

YS110, an anti-CD26 monoclonal antibody, was found to be safe in a Phase 1 clinical trial of 33 patients with CD26-positive solid tumors. Though these are very early results, the drug ... Read more

March 23, 2017

MS Therapy Fingolimod Reduces Mesothelioma Tumor Size in Mice, Study Shows

News

The multiple sclerosis therapy Fingolimod (FTY720) reduced tumor size in a mouse model of malignant mesothelioma (MM), a study demonstrated. The research, “FTY720 Inhibits Mesothelioma Growth In Vitro And In A ... Read more

March 22, 2017March 22, 2017

Tumor Thickness May Help Identify Mesothelioma Patients Needing Aggressive Treatment

News

Measuring tumor thickness may help doctors do a better job of determining which patients should have aggressive treatments for malignant pleural mesothelioma (MPM), research shows. The study, “Impact of tumour ... Read more

March 21, 2017March 21, 2017

Benefits of Keytruda in Early Pleural Mesothelioma Trial Justifies Further Studies

News

Keytruda (pembrolizumab) may benefit patients with with malignant pleural mesothelioma by targeting tumors that produce the immune checkpoint molecule PD-L1, according to an interim analysis of a Phase 1b study. The treatment ... Read more

March 20, 2017March 20, 2017

Mesothelin Drives Progression, Spread of Mesothelioma and Lung Cancer Cells, Study Finds

News

Mesothelin is essential for tumor formation, progression and metastasis in lung cancer and mesothelioma, concludes a new study that provides insights into the underlying mechanisms of both diseases and may lead to ... Read more

March 17, 2017March 17, 2017

Tissue-sparing Mesothelioma Surgery Generates Better Outcomes, Study Reports

News

Mesothelioma surgery that spares a patient’s lungs and diaphragm leads to better overall survival rates than surgery that removes part of the lungs and diaphragm, according to Italian surgeons. The ... Read more

March 16, 2017March 16, 2017

Asbestos Disease Awareness Group Protests House Passage of FACT Act

News

Linda Reinstein, president and CEO of the Asbestos Disease Awareness Organization (ADAO), has released a sharply worded statement protesting the U.S. House of Representatives’ passage of the Furthering Asbestos Claim ... Read more